Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/13/2026Strategic Partnerships Redefine China's Biotech Innovation Model: CBPF
  • 5/12/2026Singapore, China Expand Regulatory Partnership to Include Gene and Cel...
  • 5/12/2026Virax Eyes China Expansion for T-Cell Immune Profiling Platform
  • 5/12/2026BrightGene Reports Phase 3 Success for Dual GLP-1/GIP Obesity Drug BGM...
  • 5/12/2026Sihuan Pharma Completes Full H-Share Conversion of Xuanzhu Biopharm
  • 5/12/2026China Moves to Expand Maternity Insurance Coverage and Birth-Related B...
  • 5/12/2026China Expands National Pediatric Medical Center Network to Strengthen ...
  • 5/12/2026China Holds National Healthcare Reform Meeting, Prioritizes Public Hos...
  • 5/12/2026BMS Strikes Up to $15.2B Hengrui Alliance to Accelerate Global Drug De...
  • 5/12/2026China Approves Novel EGFR, JAK2 Therapies as Wave of Innovative INDs A...
  • 5/12/2026CureGene Raises Over CNY 300M in Series C Led by Walvax
  • 5/12/2026Resproly Raises New Funding to Advance Inhalation Pipeline
  • 5/12/2026DualityBio Reports Strong First-Line TNBC Data for DB-1305/BNT325 Plus...
  • 5/12/2026Starna Raises ~US$40M in Series B+ to Advance In Vivo CAR-T and Extrah...
  • 5/12/2026CytoCares Reports First-in-Human AACR Data for CD19/CD3/CD28 Trispecif...
  • 5/12/2026BeOne Culls Multiple Early Oncology Programs, Halts Phase 2 IRAK4 Degr...
  • 5/12/2026Sinocelltech Advances Dual Trispecific Antibody Combo Into Phase 1b/2 ...
  • 5/11/2026CDE Releases Draft MSC Stem Cell Product Guideline for Public Consulta...
  • 5/11/2026NMPA Releases 105th Batch of Generic Drug Reference Formulations
  • 5/11/2026NHSA Seeks Comments on 2026 NRDL and Commercial Innovation Drug List A...
  • 5/11/2026Bundxcell Completes A+ Financing to Advance iPSC-Based Regenerative Me...
  • 5/11/2026NHC Seeks Comments on Revised Human Genetic Resources Regulation Imple...
  • 5/8/2026Recent Executive Moves
  • 5/8/2026CDE Issues Revised Technical Guideline for Recombinant Insulin Product...
  • 5/8/2026China Reports 3.05M ADRs in 2025, Flags Oncology and Anti-Infective Ri...
  • 5/8/2026China Unveils Tougher Nationwide Rules Governing Medical Representativ...
  • 5/8/2026Viatris Tops Quarterly Estimates on Strong China Performance and Brand...
  • 5/8/2026China Poised to Lead Next Wave of CAR-T Innovation in Solid Tumors, Sa...
  • 5/8/2026InnoCare Advances CDH17 ADC Into Clinic as Competition Builds in GI Ca...
  • 5/8/2026LTZ Thera Raises $38M to Advance Myeloid-Engager Immunotherapy Pipelin...
  • Page:1/62 Total number of articles:1853: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group